US Broker Ratings

Cencora, Inc. (COR) Stock Analysis: A Strong Buy with 8.42% Potential Upside

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, stands tall in the healthcare sector, specifically in the medical distribution industry. With a market capitalization of $59.52 billion, Cencora is..

Illumina, Inc. (ILMN) Stock Analysis: Exploring a 21% Upside Potential Amidst Mixed Analyst Ratings

Investors eyeing opportunities in the healthcare sector might find Illumina, Inc. (NASDAQ: ILMN) an intriguing prospect. Known for its cutting-edge sequencing and array-based solutions for genetic and genomic analysis, Illumina..

Eli Lilly and Company (LLY) Stock Analysis: Unpacking the 22% Potential Upside and Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY) stands as a titan in the healthcare sector, with a market capitalization of $649.52 billion. This formidable presence in the drug manufacturing industry is..

Haleon plc (HLN) Investor Outlook: Unveiling a 31.88% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, presents a compelling investment opportunity for those eyeing the drug manufacturing industry. With a market capitalization of $39.31 billion, Haleon..

West Pharmaceutical Services (WST) Stock Analysis: A 20.8% Potential Upside Amidst Strong Analyst Ratings

For investors seeking opportunities in the healthcare sector, West Pharmaceutical Services, Inc. (NYSE: WST) presents a compelling case. With a market capitalization of $18.81 billion, this Pennsylvania-based company operates in..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 26.82% Potential Upside in Medical Devices

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, stands out as a formidable force within the medical devices industry. With a staggering market capitalization of $145.48..

ResMed Inc. (RMD) Stock Analysis: Exploring a 8.52% Upside Amid Strong Revenue Growth

ResMed Inc. (NYSE: RMD) stands out as a formidable player in the healthcare sector, particularly within the medical instruments and supplies industry. As a leading developer and distributor of medical..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Play with 18.64% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector with its focus on rare neuroendocrine diseases. This Boston-based company is gaining traction among investors, particularly due to its..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating Growth with a 7.97% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) has emerged as a noteworthy player in the healthcare sector, particularly within the medical devices industry. Based in the United States, the company specializes in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: A Potent 58.58% Upside in Biotech

Avidity Biosciences, Inc. (NASDAQ: RNA) is making waves in the biotechnology sector with its innovative approach to RNA therapeutics. As a company at the forefront of antibody oligonucleotide conjugates (AOCs),..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 24% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to capture the attention of investors with its robust standing in the biotechnology sector. With a market capitalization of nearly $99 billion, Vertex is..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Riding on a 92.10% Revenue Growth Wave

TG Therapeutics, Inc. (NASDAQ: TGTX), a key player in the biotechnology sector, is capturing investor attention with its impressive revenue growth of 92.10%. With a market capitalization of $5.63 billion,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Potential 22% Upside with Strong Buy Ratings

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, has been making waves with its pioneering genetic medicine solutions targeting high unmet medical needs. Headquartered in Pittsburgh,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring A 29% Upside Potential for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Headquartered in South Jordan, Utah, this company has been..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a 28% Upside with Strong Analyst Confidence

Royalty Pharma plc (NASDAQ: RPRX), a unique player in the healthcare sector, presents a compelling investment opportunity with a potential upside of 28.42% based on current analyst ratings. The company,..

CVS Health Corporation (CVS): Investor Outlook on a Healthcare Powerhouse with a Promising 8.88% Upside

CVS Health Corporation (NYSE: CVS) stands as a stalwart in the healthcare sector, particularly in the expansive domain of healthcare plans. With its roots firmly planted in the United States..

Integer Holdings Corporation (ITGR) Stock Analysis: A 38.79% Upside Potential in the Healthcare Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical devices industry, presents an intriguing investment opportunity with a notable upside potential. With a market cap of $3.56 billion,..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with a 32.50% Potential Upside

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is making waves in the biotechnology sector, capturing investor attention with its remarkable revenue growth and significant potential upside. With a market capitalization of $9.57..

Nuvalent, Inc. (NUVL) Stock Analysis: Unlocking a 43% Potential Upside with Promising Cancer Therapies

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is making waves in the healthcare sector with its innovative approach to cancer treatment. Specializing in the development..

DexCom, Inc. (DXCM) Investor Outlook: Analyzing the 50.77% Potential Upside in the Continuous Glucose Monitoring Market

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector, particularly within the medical devices industry, has captured the attention of investors with its promising growth trajectory in the continuous..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds